BKA
CVS icon

Brick & Kyle Associates’s CVS Health CVS Stock Holding History

Brick & Kyle Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-74,033
Closed -$5.85M – 61
2023
Q4 		$5.85M Sell
74,033
-20
-0% -$1.42K 2.91% 10
2023
Q3 		$5.17M Buy
74,053
+731
+1% +$51.8K 2.74% 12
2023
Q2 		$5.1M Buy
73,322
+864
+1% +$61.5K 2.73% 12
2023
Q1 		$5.38M Buy
72,458
+1,186
+2% +$99.5K 3.08% 11
2022
Q4 		$6.64M Sell
71,272
-919
-1% -$88.7K 3.86% 4
2022
Q3 		$6.93M Buy
72,191
+920
+1% +$91.1K 4.21% 3
2022
Q2 		$6.58M Sell
71,271
-449
-0.6% -$43.8K 3.69% 4
2022
Q1 		$7.26M Sell
71,720
-73,386
-51% -$7.71M 3.52% 7
2021
Q4 		$15M Buy
145,106
+72,869
+101% +$6.73M 3.49% 8
2021
Q3 		$6.2M Buy
72,237
+329
+0.5% +$27.6K 3.15% 6
2021
Q2 		$5.96M Buy
71,908
+191
+0.3% +$15.6K 3.11% 6
2021
Q1 		$5.36M Buy
71,717
+973
+1% +$70.9K 2.96% 8
2020
Q4 		$4.81M Sell
70,744
-139
-0.2% -$9.04K 3% 11
2020
Q3 		$4.04M Buy
70,883
+2,855
+4% +$178K 2.79% 10
2020
Q2 		$4.37M Buy
68,028
+550
+0.8% +$34.6K 3.25% 6
2020
Q1 		$4M Sell
67,478
-1,371
-2% -$91.5K 3.76% 4
2019
Q4 		$5.23M Sell
68,849
-598
-0.9% -$42K 3.98% 5
2019
Q3 		$4.58M Buy
69,447
+2,022
+3% +$120K 3.8% 6
2019
Q2 		$3.71M Buy
+67,425
New +$3.63M 3.5% 11
2017
Q1 		– Sell
-475
Closed -$37K – 425
2016
Q4 		$37K Sell
475
-25,559
-98% -$2.07M 0.03% 205
2016
Q3 		$2.32M Sell
26,034
-403
-2% -$38K 1.86% 19
2016
Q2 		$2.53M Buy
26,437
+151
+0.6% +$15K 2.08% 10
2016
Q1 		$2.73M Buy
26,286
+851
+3% +$82.7K 2.36% 7
2015
Q4 		$2.49M Buy
25,435
+24,935
+4,987% +$2.44M 2.19% 9
2015
Q3 		$48K Buy
500
+100
+25% +$10.5K 0.05% 172
2015
Q2 		$42K Hold
400
– – 0.04% 192
2015
Q1 		$41K Hold
400
– – 0.04% 196
2014
Q4 		$39K Buy
+400
New +$35.2K 0.03% 198

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brick & Kyle Associates's CVS Position: Q1 2024 in Review

Brick & Kyle Associates sold out of CVS Health (CVS) in Q1 2024, closing a stake of 74,033 shares — an estimated $5.85M sold.

Brick & Kyle Associates first reported a position in CVS in Q4 2014 and held it in 28 quarters. The position peaked at $15M in Q4 2021. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Brick & Kyle Associates reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Brick & Kyle Associates sold 74,033 CVS Health shares in Q1 2024, an estimated $5.85M.
  • Brick & Kyle Associates first reported a position in CVS Health in Q4 2014 and held it in 28 quarters.
  • Brick & Kyle Associates's CVS Health position peaked at $15M in Q4 2021.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Brick & Kyle Associates's 13F filing for Q1 2024, filed 14 May 2024.